Bionomics Limited
https://www.bionomics.com.au/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Bionomics Limited
New Company, Big Goal: Serial Entrepreneur Jonathan Lim Launches Erasca To 'Erase Cancer'
Lim, CEO of Ignyta when it was sold to Roche earlier this year, has moved on to the start-up Erasca with $42m in Series A venture cash to develop "precision oncology" drugs.
Pipeline Watch: Phase III Progress With Bempedoic Acid, Lefamulin, And Ibrutinib Combo
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Just The Tonix: New York Biotech Has Breakthrough Drug For PTSD
Tonix Pharmaceuticals has won a breakthrough therapy designation this month for its post-traumatic stress disorder drug – the most advanced product in development specifically for the condition and potentially the first ever to market targeting PTSD as its lead indication.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Genomics-Proteomics
- Other Names / Subsidiaries
-
- Eclipse Therapeutics, Inc., Iliad Chemicals Pty Limited
- Bionomics, Inc.
- Prestwick Chemical